Research Papers:

Correlation of psychooncological distress- screening and quality of life assessment in neurosurgical patients

Kira Hoffmann, Marcel Kamp, Hans-Jakob Steiger, Michael Sabel and Marion Rapp _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:111396-111404. https://doi.org/10.18632/oncotarget.22802

Metrics: PDF 1489 views  |   HTML 1968 views  |   ?  


Kira Hoffmann1, Marcel Kamp1, Hans-Jakob Steiger1, Michael Sabel1 and Marion Rapp1

1Department of Neurosurgery, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany

Correspondence to:

Marion Rapp, email: [email protected]

Keywords: glioma; HADS; distress thermometer; Po-BADO; screening

Received: September 05, 2017     Accepted: October 27, 2017     Published: November 30, 2017


Background: Cerebral tumors are associated with high rates of anxiety, depression and reduced health related quality of life. But still psychooncological screening instruments are not implemented in the daily routine of neurosurgical departments. In contrast the EORTC QLQ-C30/ EORTC QLQ- BN20 questionnaire is often used to evaluate quality of life in the framework of clinical studies. We were therefore interested, if conspicuous distress screening results are also reflected by HRQOL assessment.

Patients and Methods: Patients who were electively admitted for surgery of intracranial lesions were screened for their psychooncological distress using two self-assessment instruments (Hospital Anxiety and Depression Scale (HADS) and Distress Thermometer (DT)) and one external assessment questionnaire (Psychooncological base documentation (PO-Bado). Results were correlated with three subscales of the EORTC-QLQ-C30 and EORTC-QLQ-BN20 questionnaire.

Results: From October 2013 to March 2015, 594 patients were admitted for elective cranial neurosurgical procedure. 489 neurosurgical patients were screened for increased distress. Data from 450 patients could be correlated with the EORTC-QLQ-C30 and EORTC-QLQ-BN20. In 265 patients screening revealed increased distress. A concurrent reduced global health /higher rates of future uncertainty and conspicuous distress screening results are found in 173 patients (69.5%) compared to 30.5% of patients (n= 76) with unremarkable screening. Increased distress screening was highly significant with increased level of future uncertainty as well as decreased level of quality of life and global health (p<0.0001).

Conclusion: Psychooncological distress is accompanied by reduced quality of life, global heath and increased future uncertainty. Therefore HQOL assessment can be helpful identifying patients with increased distress.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22802